•
Jun 30, 2019

ResMed Q4 2019 Earnings Report

Total Revenue
$705M
Previous year: $624M
+13.0%
EPS
$0.95
Previous year: $0.95
+0.0%
Gross Profit
$418M
Previous year: $362M
+15.3%
Cash and Equivalents
$147M
Previous year: $189M
-22.0%
Free Cash Flow
$120M
Previous year: $112M
+7.0%
Total Assets
$4.11B
Previous year: $3.06B
+34.1%

ResMed

ResMed